COLON SPECIFIC DELIVERY OF EUDRAGIT E-100 AND EUDRAGIT-FS30D COATED TABLETS OF LEFLUNOMIDE USING CHITOSAN-CHONDROITIN SULPHATE INTERPOLYMER COMPLEX

Abstract

Objectives: In the present study, site specific colonic drug delivery system was developed on the principles of the combination of pH and microbially triggered controlled system.Methods: The basic design consists of chitosan-chondroitin sulphate inter-polymer complex containing leflunomide. The core tablet was enteric coated with Eudragit E-100 so that colon specific drug release can be achieved. The leflunomide, chitosan (CH), chondroitin sulphate (ChS), chitosan-chondroitin sulphate inter-polymer complex (CH-ChS IPC) were characterized by Fourier Transform Infrared Spectroscopy (FT-IR). In vitro drug release study was conducted using sequential dissolution technique at 0.1 N HCl buffer (simulated gastric fluid), phosphate buffer pH 7.4 (simulated intestinal fluid) and finally in phosphate buffer pH 6.8 (simulated colonic fluid) with or without rat caecal content.Results: FTIR studies confirmed that there was no interaction between drug and polymer. Tablets coated with Eudragit E-100 with different coat weights showed less than 10% of drug release in the stomach whereas same tablets showed 13.42%, 9.5%, 12.37% and 12.83% release of drug in phosphate buffer pH 7.4 and95.43%, 90.31%, 98.44% and 96.64% release of drug in phosphate buffer pH 6.8. Histopathology of rat colon after administration of Eudragit E-100 coated tablets containing chitosan-chondroitin sulphate inter-polymer complex revealed the marked reduction in acetic acid induced colitis in the test group.Conclusion: The present study confirmed that coating with Eudragit E-100 delivered the leflunomide to colon in highest efficacy with the least toxic effects of an anti-inflammatory therapy. 

Authors and Affiliations

Reetika Chopra, Kammal Preet Kaur, Neena Bedi

Keywords

Related Articles

3D QSAR AND DOCKING STUDY OF INDOLE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS

Objective: Non-steroidal anti-inflammatory agents (NSAIDs) continue to be one of the most widely used groups of therapeutic agents. QSAR (quantitative structure-activity relationship) approach is a very useful and widesp...

EFFECT OF MOMORDICA CHARANTIA FRUITS ON STREPTOZOTOCIN-INDUCED DIABETES MELLITUS AND ITS ASSOCIATED COMPLICATIONS

Objective: The present study was undertaken to assess the effect of Momordica charantia fruits on diabetes mellitus and its related complications.Methods: Crude powder, aqueous, 95% and 50% ethanol extract of Momordica c...

ENHANCING ORAL BIOAVAILABILITY OF CARVEDILOL USING SOLID DISPERSION TECHNIQUE

Objective: Carvedilol (CRV) is a beta blocker drug that is basically used for the treatment of hypertension, heart failure and arrhythmias. The objective of this study is to increase the oral bioavailability of CRV by us...

RP-UFLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CLOPIDOGREL, PANTOPRAZOLE AND ROSUVASTATIN IN HUMAN PLASMA: DRUG INTERACTION STUDIES

Objectives: Objective of our present study was to develop a novel ultra fast liquid chromatographic method for quantitative simultaneous estimation of Clopidogrel, Pantoprazole & Rosuvastatin in human plasma and to v...

ASSESSMENT OF PATIENT COUNSELLING IN DIABETIC AND HYPERTENSIVE PATIENTS IN TERMS OF PATIENT KNOWLEDGE ABOUT THEIR MEDICATION, DISEASE STATE AND LIFESTYLE MODIFICATIONS BY PHARMACY PERSONNEL AT LDF CLINIC IN MASERU

Objective: To investigate if diabetic and hypertensive patients were being adequately counselled by pharmacy personnel about their medication, disease states and lifestyle modifications at Lesotho defence force (LDF) cli...

Download PDF file
  • EP ID EP578447
  • DOI -
  • Views 82
  • Downloads 0

How To Cite

Reetika Chopra, Kammal Preet Kaur, Neena Bedi (2015). COLON SPECIFIC DELIVERY OF EUDRAGIT E-100 AND EUDRAGIT-FS30D COATED TABLETS OF LEFLUNOMIDE USING CHITOSAN-CHONDROITIN SULPHATE INTERPOLYMER COMPLEX. International Journal of Pharmacy and Pharmaceutical Sciences, 7(9), 286-291. https://europub.co.uk/articles/-A-578447